JPS5920667B2 - Sulfonamide benzamide derivatives - Google Patents

Sulfonamide benzamide derivatives

Info

Publication number
JPS5920667B2
JPS5920667B2 JP52008443A JP844377A JPS5920667B2 JP S5920667 B2 JPS5920667 B2 JP S5920667B2 JP 52008443 A JP52008443 A JP 52008443A JP 844377 A JP844377 A JP 844377A JP S5920667 B2 JPS5920667 B2 JP S5920667B2
Authority
JP
Japan
Prior art keywords
group
methylene chloride
alkyl group
residue
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52008443A
Other languages
Japanese (ja)
Other versions
JPS5392763A (en
Inventor
秀 尾形
博 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP52008443A priority Critical patent/JPS5920667B2/en
Priority to ZA00780096A priority patent/ZA7896B/en
Priority to NZ186175A priority patent/NZ186175A/en
Priority to GB2296/78A priority patent/GB1557019A/en
Priority to CA295,322A priority patent/CA1085411A/en
Priority to GR55228A priority patent/GR70058B/el
Priority to IE145/78A priority patent/IE46497B1/en
Priority to AU32687/78A priority patent/AU512057B2/en
Priority to IL53881A priority patent/IL53881A/en
Priority to DK037278A priority patent/DK154137C/en
Priority to BE184636A priority patent/BE863313A/en
Priority to FR7802210A priority patent/FR2378758A1/en
Priority to HU78SI1614A priority patent/HU176613B/en
Priority to AR270868A priority patent/AR225881A1/en
Priority to CH86678A priority patent/CH642945A5/en
Priority to SE7800982A priority patent/SE426485B/en
Priority to PH20712A priority patent/PH12853A/en
Priority to ES466366A priority patent/ES466366A1/en
Priority to DE19782803651 priority patent/DE2803651A1/en
Priority to NL7801005A priority patent/NL7801005A/en
Publication of JPS5392763A publication Critical patent/JPS5392763A/en
Priority to US05/967,011 priority patent/US4351770A/en
Priority to US06/124,726 priority patent/US4350635A/en
Priority to US06/124,727 priority patent/US4328155A/en
Priority to US06/124,728 priority patent/US4328344A/en
Priority to US06/162,793 priority patent/US4330472A/en
Priority to US06/398,702 priority patent/US4431663A/en
Publication of JPS5920667B2 publication Critical patent/JPS5920667B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Description

【発明の詳細な説明】 本発明は一般式 〔式中、Rは水素、アルキル基、シアノ基、アルカンス
ルホニル基又はジアルキルアミノ基を表わし;R1はア
ルキル基、アリール基又はジアルキルアミノ基を表わし
;R2は水素、ハロゲン、アルキル基、ジアルキルアミ
ノ基又はアルコキシ基を表わし:R4はアルコキシ基を
表わし:R3およびR5は各々水素、アルキル基又はア
ルコキシ基を表わし;R6はアルキル基又はシクロアル
キル基を表わす。
DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula [wherein R represents hydrogen, an alkyl group, a cyano group, an alkanesulfonyl group, or a dialkylamino group; R1 represents an alkyl group, an aryl group, or a dialkylamino group; R2 represents hydrogen, halogen, an alkyl group, a dialkylamino group, or an alkoxy group; R4 represents an alkoxy group; R3 and R5 each represent hydrogen, an alkyl group, or an alkoxy group; R6 represents an alkyl group or a cycloalkyl group. .

〕で示される化合物又はその塩に関する。] or a salt thereof.

これらの目的物質は医薬又は動物薬、とりわけ抗胃潰瘍
剤又は向精神薬としての用途が期待できる。上記目的物
質(1)の定義において使用される用語について具体例
を以下に示す。
These target substances can be expected to be used as medicines or veterinary medicines, especially as anti-gastric ulcer agents or psychotropic agents. Specific examples of the terms used in the definition of the target substance (1) above are shown below.

アルキル基(例えば、メチル、エチル、プロピル、イソ
プロピル、ブチル、イソブチル、ペンチル、ヘキシル)
、アルカンスルホニル基(例えば、メタンスルホニル、
エタンスルホニル、プロパンスルホニル、ブタンスルホ
ニル、イソブタンスルホニル)、ジアルキルアミノ基(
例えば、ジメチルアミノ、ジエチルアミノ、メチルエチ
ルアミノ、エチルプロピルアミノ、メチルブチルアミノ
)、アリール基(例えば、フエニル、トリル、キシリル
、ナフチル)、ハロゲン(例えば、フツ素、塩素、臭素
、ヨウ素)、アルコキシ基(例えば、メトキシ、エトキ
シ、プロポキシ、ブトキシ、ペントキシ)、シクロアル
キル基(例えば、シクロプロピル、シクロブチル、シク
ロペンチル、シクロヘキシル)。
Alkyl groups (e.g. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl)
, alkanesulfonyl groups (e.g. methanesulfonyl,
ethanesulfonyl, propanesulfonyl, butanesulfonyl, isobutanesulfonyl), dialkylamino group (
For example, dimethylamino, diethylamino, methylethylamino, ethylpropylamino, methylbutylamino), aryl groups (e.g. phenyl, tolyl, xylyl, naphthyl), halogens (e.g. fluorine, chlorine, bromine, iodine), alkoxy groups (eg, methoxy, ethoxy, propoxy, butoxy, pentoxy), cycloalkyl groups (eg, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl).

目的物質(1)は、下記の図式で示されるように、原料
アニリン類(0をスルホン化(ルートA)するか、また
は安息香酸類もしくはその反応性誘導体(IV)にアミ
ン類(V)を反応させ(ルートD)、必要により、さら
に水解(ルートB)もしくはアルキル化(ルートC)の
化学修飾を施して得られる。
The target substance (1) is obtained by sulfonating the raw material aniline (0) (route A) or by reacting amines (V) with benzoic acids or their reactive derivatives (IV), as shown in the diagram below. (Route D) and, if necessary, further chemically modified by hydrolysis (Route B) or alkylation (Route C).

〔式中、Aは反応性基(例えば,ハロゲン,エステル残
基,−0S02R1なる基),A1はヒドロキシ基また
は反応性基(例えば.ハロゲン、エステル残基)を表わ
し,R,Rl,R2,R3,R4,R5およびROは前
記と同意義を有する。
[In the formula, A represents a reactive group (e.g., halogen, ester residue, -0S02R1 group), A1 represents a hydroxy group or a reactive group (e.g., halogen, ester residue), R, Rl, R2, R3, R4, R5 and RO have the same meanings as above.

〕ルートA本反応は原料アニリン類()にスルホン化剤
(自)を反応させてスルホンアミド(1)を形成する反
応である。
] Route A This reaction is a reaction in which a sulfonating agent (self) is reacted with a raw material aniline ( ) to form a sulfonamide (1).

スルホン化剤(自)は所定のスルホン酸のハロゲニド(
例えば、クロリド,プロミド)、活性エステル(例えば
.p−ニトロフエニルエステル●ベンジルエステル,ト
リチルエステル)および無水物(例えば、無水メタンス
ルホン酸、無水エタンスルホン酸)を含有する。本反応
はスルホン化の常法によつて実施すればよく6一般には
適当な不活性溶媒(例えば,塩化メチレン,ベンゼン,
テトラヒドロフラン,ジオキサン)の存在下または不存
在下に、必要なら、適当な脱酸剤(例えば、トリエチル
アミン6ピリジンなどの有機アミン6炭酸カリウム,重
炭酸ナトリウムなどの無機塩基)を加えて実施するか,
あるいは溶媒と脱酸剤を兼ねて有機アミン(例えば,ピ
リジン,トリエチルアミン)を使用して実施すればよい
。反応温度は通常室温下または冷却もしくは加熱下であ
る。一般に本反応は好収率下に進行するが、使用する溶
媒と脱酸剤の種類によつてはモノスルホン化生成物、ジ
スルホン化生成物または両者の混合物が生成することが
あるが,これらはいずれも目的化合物(1)に包含され
る。ルートB 上記ルートAでの生成物(1)のうちジスルホン化生成
物は6必要なら、水解してモノスルホン化生成物(1a
)に変換できる。
The sulfonating agent (self) is a halide of the specified sulfonic acid (
For example, chloride, bromide), active esters (e.g., p-nitrophenyl ester, benzyl ester, trityl ester), and anhydrides (e.g., methanesulfonic anhydride, ethanesulfonic anhydride). This reaction may be carried out using a conventional sulfonation method.6 Generally, a suitable inert solvent (e.g. methylene chloride, benzene,
(tetrahydrofuran, dioxane), if necessary, with the addition of a suitable deoxidizing agent (e.g., an organic amine such as triethylamine 6-pyridine, an inorganic base such as potassium hexacarbonate, sodium bicarbonate, etc.), or
Alternatively, an organic amine (eg, pyridine, triethylamine) may be used as both a solvent and a deoxidizing agent. The reaction temperature is usually room temperature or under cooling or heating. Generally, this reaction proceeds with a good yield, but depending on the type of solvent and deoxidizing agent used, monosulfonated products, disulfonated products, or a mixture of the two may be produced. All are included in the target compound (1). Route B Among the products (1) in route A above, the disulfonated product 6 is hydrolyzed, if necessary, to form the monosulfonated product (1a
) can be converted to

本反応は常法により無機または有機塩基(例えば,水酸
化ナトリウム6水酸化カリウム6炭酸カリウム,重炭酸
ナトリウム、ナトリウムメトキシド,カリウムエトキシ
ド)にて適当な溶媒(例えば、水6メタノール,エタノ
ール、アセトン,ジオキサン)中室温下または加熱下に
処理すればよい。ルートC 上記ルートAでの生成物(1)のうち活性水素(R=水
素)を有する化合物は、必要なら6アルキル化してN−
アルキルスルホンアミド(Ib:R=アルキル基)に変
換でさる。
This reaction is carried out in a conventional manner using an inorganic or organic base (e.g., sodium hydroxide, potassium hexahydroxide, potassium hexacarbonate, sodium bicarbonate, sodium methoxide, potassium ethoxide) in a suitable solvent (e.g., water, methanol, ethanol, It may be treated in acetone, dioxane) at room temperature or under heat. Route C Among the products (1) in Route A above, compounds having active hydrogen (R=hydrogen) can be 6-alkylated to N-
It is converted into an alkylsulfonamide (Ib: R=alkyl group).

本反応はアミノ基のアルキル化のための常法によつて実
施すればよく6通常ジアルキル硫酸(例えば、ジメチル
硫酸6ジエチル硫酸)またはハロゲン化アルキル(例え
ば6ヨウ化メチル,臭化エチル、塩化プロピル)などの
アルキル化剤/アルカリ(例えば,水酸化ナトリウム6
水酸化カリウム、炭酸カリウム6重炭酸ナトリウム)と
適当な溶媒(例えば6水、アセトン,ジオキサン、テト
ラヒドロフラン,ジメチルスルホキシド)中室温下また
は加熱下に実施される。上記ルートAで原料物質として
使用されるアニリン類()は特公昭44−23496号
公報に記載の方法に準じて合成される。
This reaction may be carried out by a conventional method for alkylating an amino group.6 Usually dialkyl sulfuric acid (e.g., dimethyl sulfate, 6-diethyl sulfate) or alkyl halide (e.g., 6-methyl iodide, ethyl bromide, propyl chloride) is used. ) such as alkylating agents/alkali (e.g. sodium hydroxide 6
The reaction is carried out in potassium hydroxide, potassium carbonate, hexasodium bicarbonate) and a suitable solvent (for example, hexawater, acetone, dioxane, tetrahydrofuran, dimethyl sulfoxide) at room temperature or under heating. Anilines () used as raw materials in route A above are synthesized according to the method described in Japanese Patent Publication No. 44-23496.

〔式中.Al,R2,R3,R4,R5およびR6は前
記と同意義を有する。
[During the ceremony. Al, R2, R3, R4, R5 and R6 have the same meanings as above.

〕ルートD 本反応は安息香酸類もしくはその反応性誘導体(5)と
アミン類(7)の縮合反応であつて,この種の反応の常
法に従つて実施される。
[Route D] This reaction is a condensation reaction of benzoic acids or their reactive derivatives (5) and amines (7), and is carried out according to a conventional method for this type of reaction.

一般には安息香酸類のアルキルエステルもしくは酸ハロ
ゲニドとアミン類(とを.必要なら,適当な脱酸剤(例
えば、トリエチルアミン,ピリジン,ピコリン、水酸化
ナトリウム、炭酸カリウム)の存在下に不活性溶媒(例
えばエタノール、プロパノール・ジオキサン・ジメチル
ホルムアミド、ベンゼン、塩化メチレン)中加熱して反
応を行えばよい。ルートDで原料物質として使用する安
息香酸類もしくはその反応性誘導体(5)は、例えば6
対応するアミノ安息香酸類(ロ)をスルホン化すること
によって得られる。
Generally, alkyl esters of benzoic acids or acid halides and amines are mixed together in an inert solvent (e.g., The reaction may be carried out by heating in ethanol, propanol/dioxane/dimethylformamide, benzene, methylene chloride).The benzoic acids or their reactive derivatives (5) used as raw materials in route D are, for example, 6
Obtained by sulfonating the corresponding aminobenzoic acid (b).

〔式中6Etはエチル基を表わし.A,R,Rl,lO
R2,R3,R4およびR5は前記と同意義を有する〕
本発明の目的物質(1)は、製剤化、結晶化6溶解性ま
たは安定性の向上などの必要性のために無機酸(例えば
、塩酸6臭化水素酸、硫酸,リン酸、チオシアン酸)や
有機酸(例えば、酢酸、コハク 15酸、シユウ酸,マ
レイン酸,リンゴ酸,フタル酸6メタンスルホン酸、ク
エン酸、トルエンスルホン酸6酒石酸)などの酸付加塩
の如き製剤上許容できる酸付加塩に導くことができる。
[In the formula, 6Et represents an ethyl group. A, R, Rl, lO
R2, R3, R4 and R5 have the same meanings as above]
The target substance (1) of the present invention is an inorganic acid (e.g., hydrochloric acid, hexahydrobromic acid, sulfuric acid, phosphoric acid, thiocyanic acid) for the purpose of improving formulation, crystallization, solubility, or stability. and pharmaceutically acceptable acid addition salts of organic acids (e.g., acetic acid, succinic acid, oxalic acid, maleic acid, malic acid, phthalic acid, hexamethanesulfonic acid, citric acid, toluenesulfonic acid, hexatartaric acid). It can lead to salt.

本発明の目的物質(1)は右旋性および左旋性の光20
学異性体を含むものであつて、これらはラセミ化合物か
ら常法によつて容易に分割することができる。
The target substance (1) of the present invention is dextrorotatory and levorotatory light 20
It contains chemical isomers, and these can be easily separated from racemic compounds by conventional methods.

目的物質(1)およびそれらの製剤上許容できる酸付加
塩は抗胃潰瘍剤または向精神薬、とくに抗精25神病剤
(メージヤートランキライザ一)として有用である。
The target substance (1) and its pharmaceutically acceptable acid addition salts are useful as anti-gastric ulcer agents or psychotropic agents, particularly as antipsychotic agents (Mesier Tranquilizer 1).

例えば6N−(1−エチル−2−ピロリジニルメチル)
−2−メトキシ−4−クロロ−5−メタンスルホンアミ
ドベンズアミドは,成犬におけるアポモルピン拮抗の制
吐試験において0.01mg/Kg(経口投与)で有効
であつた。その他の目的物質(1)も同様の薬理作用を
示した。スルホンアミド系ベンズアミド類(1)および
それらの製剤上許容できる酸付加塩は単独でまたは小麦
でんぷん,トウモロコシでんぷん,じやがいも 35で
んぷん、ゼラチン、水などの製剤上適当な担体を添加し
て、経口または非経口的に使用される。担体の選択は好
ましい投与方法、使用する物質の溶解性および標準的な
製剤慣行によつて行えばよい。製剤する剤型としては、
錠剤、カプセル,ピ 菊ル6懸濁液6シロツプ、粉末、
溶液などが例示される。これらの組成物は常法により製
剤化され得る。例えば、抗精神病剤として使用するとき
6スルホンアミド系ベンズアミド類(1)およびそれら
の?剤上許容できる酸付加塩の成人に対する適当な之与
量は,経口投与で約1〜約3501119/日であ以下
に本発明の実施例を示す。辷施例 1 1) 2−メトキシ−4−クロロ−5−ニトロ安息香酸
(Helv.Chim.Acta.,(曵,369(1
959))9001!9および塩化チオニル5dからな
る混合物を30分間還流し6塩化チオニルを留去する。
For example, 6N-(1-ethyl-2-pyrrolidinylmethyl)
-2-Methoxy-4-chloro-5-methanesulfonamide benzamide was effective at 0.01 mg/Kg (oral administration) in an antiemetic test of apomorphine antagonism in adult dogs. Other target substance (1) also showed similar pharmacological effects. Sulfonamide benzamides (1) and their pharmaceutically acceptable acid addition salts can be used alone or with the addition of a pharmaceutically appropriate carrier such as wheat starch, corn starch, potato starch, gelatin, water, etc. Used orally or parenterally. The choice of carrier may be determined by the preferred method of administration, the solubility of the material used, and standard pharmaceutical practices. The dosage form to be prepared is as follows:
tablets, capsules, pills, chrysanthemum 6 suspension 6 syrup, powder,
Examples include solutions. These compositions can be formulated by conventional methods. For example, when used as an antipsychotic, 6-sulfonamide benzamides (1) and their ? A suitable dosage for adults of pharmaceutically acceptable acid addition salts is from about 1 to about 3,501,119 per day by oral administration, and examples of the present invention are shown below. Example 1 1) 2-methoxy-4-chloro-5-nitrobenzoic acid (Helv.Chim.Acta., (曵, 369(1)
959)) A mixture consisting of 9001!9 and thionyl chloride 5d is refluxed for 30 minutes to distill off thionyl hexachloride.

残渣にベンゼンを加え6ベンゼンを留去する。残渣にト
リエチルアミン790即および乾燥塩化メチレン9Tf
1fを加え、氷冷攪拌下にこれに1−エチル−2−アミ
ノメチルピロリジン750即および塩化メチレン4m1
からなる溶液を滴下し.15分間室温に攪拌する。
Benzene is added to the residue and 6 benzene is distilled off. Add triethylamine 790 and dry methylene chloride 9Tf to the residue.
1f was added, and 750 ml of 1-ethyl-2-aminomethylpyrrolidine and 4 ml of methylene chloride were added thereto under ice-cooling and stirring.
Drop a solution consisting of Stir for 15 minutes at room temperature.

反応液に炭酸水素ナトリウム水溶液を加え6塩化メチレ
ンにて抽出する。有機層を水洗し、芒硝にて乾燥し6溶
媒を留去する。残渣にエーテルを加え6希塩酸にて抽出
する。水層を重炭酸ナトリウム水溶液にてアルカリ性と
し、塩化メチレンにて抽出する。有機層を水洗し,乾燥
し6溶媒を留去する。残渣を酢酸エチル/イソプロピル
エーテルにて再結晶し6融点107〜108℃の結晶と
してN−(1−エチル−2−ピロリジニルメチル)−2
−メトキシ−4−クロロ−5−ニトロベンズアミド67
97!9を得る。
An aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with methylene hexachloride. The organic layer was washed with water, dried with Glauber's salt, and the solvent was distilled off. Ether was added to the residue and extracted with 6 dilute hydrochloric acid. The aqueous layer is made alkaline with an aqueous sodium bicarbonate solution and extracted with methylene chloride. The organic layer is washed with water, dried, and the solvent is distilled off. The residue was recrystallized from ethyl acetate/isopropyl ether to give N-(1-ethyl-2-pyrrolidinylmethyl)-2 as crystals with a melting point of 107-108°C.
-methoxy-4-chloro-5-nitrobenzamide 67
97! Get 9.

2)上記生成物7.339を濃塩酸36.7m1および
水73.3m1からなる溶液に加え,50℃に加温し、
スズ片7.7f1を加え650℃で4時間攪拌する。
2) Add 7.339 of the above product to a solution consisting of 36.7 ml of concentrated hydrochloric acid and 73.3 ml of water and heat to 50°C,
Add 7.7 f1 tin pieces and stir at 650°C for 4 hours.

冷後,反応液を水酸化ナトリウム水溶液にてアルカリ性
とし,塩化メチレンにて抽出する。有機層を水洗し、芒
硝にて乾燥し、溶媒を留去する。残渣をアルミナカラム
にてクロマトグラフイ一に付し,塩化メチレンにて溶出
し、溶媒を留去する。残渣をイソプロピルエーテル/石
油エーテルにて洗滌すると,N−(1−エチル−2−ピ
ロリジニルメチル)−2−メトキシ−4−クロロ−5−
アミノベンズアミド5.389を得る。
After cooling, the reaction solution is made alkaline with an aqueous sodium hydroxide solution and extracted with methylene chloride. The organic layer was washed with water, dried over Glauber's salt, and the solvent was distilled off. The residue was chromatographed on an alumina column, eluted with methylene chloride, and the solvent was distilled off. When the residue was washed with isopropyl ether/petroleum ether, N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-4-chloro-5-
5.389 aminobenzamide is obtained.

本品をイソプロピルエーテル/石油エーテルにて再結晶
すると、融点85〜86.5℃の結晶となる。(3)上
記生成物4.19,トリエチルアミン2.939および
乾燥塩化メチレン41dからなる溶液に、氷冷下メタン
スルホニルクロリド3.18f!および乾燥塩化メチレ
ン7.2dからなる溶液を滴下する。
When this product is recrystallized from isopropyl ether/petroleum ether, it becomes crystals with a melting point of 85-86.5°C. (3) Add 3.18 f of methanesulfonyl chloride to a solution consisting of 4.19 of the above product, 2.939 of triethylamine, and 41 d of dry methylene chloride under ice cooling! and 7.2 d of dry methylene chloride are added dropwise.

氷浴を外し、室温にて45分間撹拌する。反応液に重炭
酸ナトリウム水溶液を加えてアルカリ性とし,塩化メチ
レンにて抽出する。有機層を水洗し、芒硝にて乾燥し、
溶媒を留去する。残渣を酢酸エチル−イソプロピルエー
テルにて洗滌し,融点153〜155℃の結晶としてN
−(1−エチル−2−ピロリジニルメチル)−2−メト
キシ−4−クロロ−5−N,N−ビス(メタンスルホニ
ル)アミノベンズアミド5.839を得る。(4)上記
生成物5.759および10%水酸化ナトリウム57.
5dからなる懸濁液を50℃に加熱下に30分間攪拌す
る。
Remove the ice bath and stir at room temperature for 45 minutes. The reaction solution is made alkaline by adding aqueous sodium bicarbonate solution, and extracted with methylene chloride. The organic layer was washed with water, dried with Glauber's salt,
The solvent is distilled off. The residue was washed with ethyl acetate-isopropyl ether to give N as crystals with a melting point of 153-155°C.
-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-4-chloro-5-N,N-bis(methanesulfonyl)aminobenzamide 5.839 is obtained. (4) The above product 5.759 and 10% sodium hydroxide 57.
The suspension consisting of 5d is heated to 50° C. and stirred for 30 minutes.

冷後,反応液を濃塩酸にて酸性とし、次いで炭酸水素ナ
トリウム水溶液にてアルカリ性とし,食塩を飽和させ6
塩化メチレンにて抽出する。有機層を飽和食塩水にて洗
滌し,芒硝で乾燥し,塩化メチレンを留去する。残渣を
アルミナカラムにてクロマトグラフイ一に付し、塩化メ
チレン単独および2%メタノール/塩化メチレンにて溶
出し6溶出液から溶媒を留去する。残渣を酢酸エチル/
イソプロピルエーテルにて洗滌し,N−(1−エチル−
2−ピロリジニルメチル)−2−メトキシ−4−クロロ
−5−メタンスルホンアミドベンズアミド4.3gを得
る。本品を酢酸エチル/イソプロピルエーテルから再結
晶し6融点126〜127.5℃の無色プリズム晶とな
る。実施例 2 N−(1−エチル−2−ピロリジニルメチノ(ハ)−2
−メトキシ−5−アミノベンズアミド700119,ト
リエチルアミン1.029及び塩化メチレン14dから
なる混液に室温で攪拌下メタンスルホニルクロリド87
01!9を滴下し,室温で1時間攪拌する。
After cooling, the reaction solution was made acidic with concentrated hydrochloric acid, then made alkaline with an aqueous sodium bicarbonate solution, and saturated with common salt.
Extract with methylene chloride. The organic layer is washed with saturated brine, dried over sodium sulfate, and methylene chloride is distilled off. The residue was chromatographed on an alumina column, eluted with methylene chloride alone and 2% methanol/methylene chloride, and the solvent was distilled off from the eluate. The residue was dissolved in ethyl acetate/
After washing with isopropyl ether, N-(1-ethyl-
4.3 g of 2-pyrrolidinylmethyl)-2-methoxy-4-chloro-5-methanesulfonamide benzamide are obtained. This product is recrystallized from ethyl acetate/isopropyl ether to give colorless prismatic crystals with a melting point of 126-127.5°C. Example 2 N-(1-ethyl-2-pyrrolidinylmethino(c)-2
-87% of methanesulfonyl chloride was added to a mixture of 700119 methoxy-5-aminobenzamide, 1.029% of triethylamine, and 14d of methylene chloride with stirring at room temperature.
01!9 was added dropwise and stirred at room temperature for 1 hour.

反応液に水を加え、重炭酸ナトリウム水溶液にてアルカ
リ性とし,塩化メチレンで抽出する。有機層を水洗し、
芒硝にて乾燥し.塩化メチレンを留去する。残渣をアル
ミナによるカラムクロマトグラフイ一に付し、塩化メチ
レンにて溶出させる。溶出液から溶媒を留去し6残渣を
酢酸エチル/イソプロピルエーテルにて結晶化し,N−
(1−エチル−2−ピロリジニルメチル)−2ーメトキ
シ−5−N,N−ビス(メタンスルホニル)アミドノベ
ンズアミド5821!9を得る。本品を酢酸エチルより
再結晶し、融点160〜161℃の結晶を得る。次いで
、溶出液を3%メタノール/塩化メチレンすると.N−
(1−エチル−2−ピロリジニルメチル)−2−メトキ
シ−5−メタンスルホンアミドベンズアミドを与える。
Water is added to the reaction solution, made alkaline with an aqueous sodium bicarbonate solution, and extracted with methylene chloride. Wash the organic layer with water,
Dry with Glauber's salt. Distill off methylene chloride. The residue was subjected to column chromatography using alumina and eluted with methylene chloride. The solvent was distilled off from the eluate, and the residue 6 was crystallized from ethyl acetate/isopropyl ether.
(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-N,N-bis(methanesulfonyl)amidonobenzamide 5821!9 is obtained. This product is recrystallized from ethyl acetate to obtain crystals with a melting point of 160-161°C. The eluate was then diluted with 3% methanol/methylene chloride. N-
(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-methanesulfonamide benzamide is obtained.

溶出液を濃縮したのち,残渣を酢酸エチル/イソプロピ
ルエーテルにて結晶化すると生成物148即を得る。本
品を酢酸エチルより再結晶すると融点170〜171℃
の結晶となる。(2) N−(1−エチル−2−ピロリ
ジニルメチル)一2−メトキシ−5−N,N−ビス(メ
タンスルホニル)アミノベンズアミド290W9,10
?水酸化ナトリウム水溶液2.9dおよびメタノール2
.9m1からなる懸濁液を氷浴上5分間加熱すると透明
な溶液となる。
After concentrating the eluate, the residue is crystallized from ethyl acetate/isopropyl ether to yield product 148. When this product is recrystallized from ethyl acetate, the melting point is 170-171℃.
It becomes a crystal. (2) N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-N,N-bis(methanesulfonyl)aminobenzamide 290W9,10
? 2.9 d of sodium hydroxide aqueous solution and 2 d of methanol
.. A suspension of 9 ml is heated on an ice bath for 5 minutes to give a clear solution.

溶媒を留去したのち6残渣に氷水を加え、6N塩酸にて
酸性とし6次いで重炭酸ナトリウム水溶液を加えて弱ア
ルカリ性とし、塩化メチレンにて抽出する。有機層を水
洗し6芒硝にて乾燥し,溶媒を留去する。残渣を酢酸エ
チル/イソプロピルエーテルにて洗滌し.N−(1−エ
チル−2−ピロリジニルメチル)−2−メトキシ−5−
メタンスルホンアミドベンズアミド148mgを得る。
本品を酢酸エチル/イソプロピルエーテルにて再結晶し
,融点170〜171.5℃の結晶となる。実施例 3 (1) N−(1−エチル−2−ピロリジニルメチル)
−2−メトキシ−5−アミノベンズアミド700η,塩
化メチレン14m1およびトリエチルアミン1.039
からなる混合液に室温下にベンゼンスルホニルクロリド
1.359を加え6室温下に一夜放置する。
After the solvent was distilled off, ice water was added to the residue, acidified with 6N hydrochloric acid, made weakly alkaline with an aqueous sodium bicarbonate solution, and extracted with methylene chloride. The organic layer was washed with water, dried over 6-milk salt, and the solvent was distilled off. Wash the residue with ethyl acetate/isopropyl ether. N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-
148 mg of methanesulfonamide benzamide are obtained.
This product is recrystallized from ethyl acetate/isopropyl ether to give crystals with a melting point of 170-171.5°C. Example 3 (1) N-(1-ethyl-2-pyrrolidinylmethyl)
-2-methoxy-5-aminobenzamide 700η, methylene chloride 14ml and triethylamine 1.039
1.359 g of benzenesulfonyl chloride was added to the mixture at room temperature, and the mixture was left at room temperature overnight.

反応液に水を加え,重炭酸ナトウム水溶液にてアルカリ
性とし、塩化メチレンにて抽出する。有機層を水洗し6
芒硝で乾燥し、溶媒を留去する。残渣を塩化メチレンに
溶解し,アルミナカラムによるクロマトグラフイ一に付
し、塩化メチレンにて溶出する。溶出液から塩化メチレ
ンを留去し、残渣を酢酸エチル/イソプロピルエーテル
から再結晶し、融点166〜170℃の結晶としてN−
(1−エチル−2−ピロリジニルメチル)−2−メトキ
シ−5−N,N−ビス(ベンゼンスルホニル)アミノベ
ンズアミド839即を得る。x (2)..上記の生成物500即,1070水酸化ナト
リウム7.5m1およびメタノール7.5m1からなる
混合液を氷浴上5分間加温する。
Add water to the reaction solution, make it alkaline with an aqueous sodium bicarbonate solution, and extract with methylene chloride. Wash the organic layer with water6
Dry with Glauber's salt and evaporate the solvent. The residue was dissolved in methylene chloride and subjected to chromatography using an alumina column, eluting with methylene chloride. Methylene chloride was distilled off from the eluate, and the residue was recrystallized from ethyl acetate/isopropyl ether to give N-
(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-N,N-bis(benzenesulfonyl)aminobenzamide 839 is obtained. x (2). .. A mixture of the above product 500, 7.5 ml of 1070 sodium hydroxide and 7.5 ml of methanol is heated on an ice bath for 5 minutes.

反応液からメタノールを留去し6残渣に水を加え,塩酸
酸性とし、重炭酸ナトリウム水溶液にて再びアルカリ性
とし、塩化メチレンにて抽出する。有機層を乾燥し6溶
媒を留去する。残渣を酢酸エチル/イソ菊プロピルエー
テルにて洗滌し.N−(1−エチル−2−ピロリジニル
メチル)−2−メトキシ−5−ベンゼンスルホンアミド
ベンズアミド325W19得る。
Methanol is distilled off from the reaction solution, water is added to the residue, acidified with hydrochloric acid, made alkaline again with an aqueous sodium bicarbonate solution, and extracted with methylene chloride. The organic layer is dried and the solvent is distilled off. Wash the residue with ethyl acetate/isokikupropyl ether. N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-benzenesulfonamide benzamide 325W19 is obtained.

本品を酢酸エチルより再結晶し、融点177〜178℃
の結晶となる。辷施例 4 i) N−(1−エチル−2−ピロリジニルメチル)一
2−メトキシ−5−ニトロベンズアミド1.596酸化
白金150mgおよびメタノール30dからなる混合液
を水素気流中振盪して接触還元を行う。
This product was recrystallized from ethyl acetate, melting point 177-178℃.
It becomes a crystal. Example 4 i) N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-nitrobenzamide 1.596 A mixture of 150 mg of platinum oxide and 30 d of methanol was brought into contact by shaking in a hydrogen stream. Give back.

反応液を常法通り処理して6メタノールを留去する。残
渣にナトリウムアジド500mg、オルトギ酸エチル5
m1および酢酸5m1を加え680℃にて1時間加温す
る。反応液に氷水を加え,炭酸ナトリウムにてアルカリ
性とし,塩化メチレンにて抽出する。有機層を水洗し6
芒硝にて乾燥し、溶媒を留去する。残渣を酢酸エチル/
イソプロピルエーテルにて結晶化し、融点171〜17
4℃の結晶としてN−(1−エチル−2−ピロリジニル
メチル)−2−メトキシ−5−(1H−テトラゾール−
1−イル)ベンズアミド1.3f!を得る。2)上記生
成物1.39.エタノール9.8m1.水33dおよび
1070水酸化ナトリウム6.5dからなる混合液を8
0℃で40分間加温する。
The reaction solution is treated in a conventional manner to distill off 6 methanol. 500 mg of sodium azide and 5 ethyl orthoformate to the residue
ml and 5 ml of acetic acid were added and heated at 680°C for 1 hour. Add ice water to the reaction solution, make alkaline with sodium carbonate, and extract with methylene chloride. Wash the organic layer with water6
Dry with Glauber's salt and evaporate the solvent. The residue was dissolved in ethyl acetate/
Crystallized from isopropyl ether, melting point 171-17
N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-(1H-tetrazole-
1-yl)benzamide 1.3f! get. 2) The above product 1.39. Ethanol 9.8ml 1. 8 d of a mixed solution consisting of 33 d of water and 6.5 d of 1070 sodium hydroxide.
Warm at 0°C for 40 minutes.

エタノールを留去し6残渣を6N塩酸にて酸性とし,次
いでトリエチルアミンにて塩基性とし,食塩で塩析し.
5%メタノール/塩化メチレンにて抽出する。有機層を
芒硝にて乾燥し、溶媒を留去する。残渣を酢酸エチルで
洗滌しN−(1−エチル−2−ピロリジニルメチル)−
2−メトキシ−5−シアノアミノベンズアミド641T
11fを得る。本品を酢酸エチルから再結晶すると融点
134〜139℃の結晶となる。(3)上記生成物30
0′11Iflおよびピリジン1.5−からなる溶液に
室温下メタンスルホニルクロリド340即を加え、室温
で2時間撹拌し650℃で30分間攪拌する。
Ethanol was distilled off, and the residue was made acidic with 6N hydrochloric acid, then made basic with triethylamine, and salted out with common salt.
Extract with 5% methanol/methylene chloride. The organic layer was dried with Glauber's salt and the solvent was distilled off. The residue was washed with ethyl acetate and N-(1-ethyl-2-pyrrolidinylmethyl)-
2-Methoxy-5-cyanoaminobenzamide 641T
11f is obtained. When this product is recrystallized from ethyl acetate, it becomes crystals with a melting point of 134-139°C. (3) The above product 30
To a solution consisting of 0'11 Ifl and 1.5-pyridine was added 340 ml of methanesulfonyl chloride at room temperature, and the mixture was stirred at room temperature for 2 hours and then at 650°C for 30 minutes.

反応液に炭酸ナトリウム水溶液を加え、塩化メチレンに
て抽出する。有機層を水洗し6芒硝で乾燥し6溶媒を留
去する。残渣を塩化メチレンに溶解し,アルミナカラム
によるクロマトグラフイ一に付し6塩化メチレンにて溶
出させる。溶出液から塩化メチレンを留去し,残渣をエ
ーテル/イソプロピルエーテルにて洗滌し,次いで再結
晶すると融点50〜54℃の結晶としてN−(1−エチ
ル−2−ピロリジニルメチル)−2−メトキシ−5−N
−シアノメタンスルホンアミドベンズアミド99mgを
得る。V9V●UU 実施例 5 N−(1−エチル−2−ピロリジニルメチノ(ハ)一2
−メトキシ−5−エタンスルホンアミドベンズアミド2
66111fI,乾燥アセトン7D,炭酸カリウム20
0111fおよびジメナル硫酸100711fを混合し
.30分間還流する。
Add an aqueous sodium carbonate solution to the reaction mixture, and extract with methylene chloride. The organic layer was washed with water, dried with 6-mg sodium sulfate, and the 6-solvent was distilled off. The residue was dissolved in methylene chloride and subjected to chromatography using an alumina column and eluted with methylene hexachloride. Methylene chloride was distilled off from the eluate, the residue was washed with ether/isopropyl ether, and then recrystallized to give N-(1-ethyl-2-pyrrolidinylmethyl)-2- as crystals with a melting point of 50-54°C. Methoxy-5-N
- Obtain 99 mg of cyanomethanesulfonamide benzamide. V9V●UU Example 5 N-(1-ethyl-2-pyrrolidinylmethino(c)-2
-Methoxy-5-ethanesulfonamide benzamide 2
66111fI, dry acetone 7D, potassium carbonate 20
0111f and Dimenal Sulfate 100711f were mixed. Reflux for 30 minutes.

アセトンを留去し6残渣に水を加え,塩化メチレンにて
抽出する。有機層を水洗し、芒硝にて乾燥し6溶媒を留
去する。残渣を塩化メチレンに溶解し6アルミナカラム
によるクロマトグラフイ一に付し、塩化メチレンにて溶
出させる。溶出液から塩化メチレンを留去し,残渣をイ
ソプロピルエーテルにて洗滌し、次いで酢酸エチル/イ
ソプロピルエーテルより再結晶し2融点85〜87℃の
結晶としてN−(1−エチル−2−ピロリジニルメチル
)−2−メトキシ−5−(N−メチルエタンスルホニル
アミノ)ベンズアミド74ηを得る。j 下記の原料化合物(9)を使用して,実施例1と同貢に
して反応を行い、対応する生成物(1)を得る。
Acetone was distilled off, water was added to the residue, and the mixture was extracted with methylene chloride. The organic layer was washed with water, dried with Glauber's salt, and the solvent was distilled off. The residue was dissolved in methylene chloride and subjected to chromatography using a 6-alumina column and eluted with methylene chloride. Methylene chloride was distilled off from the eluate, the residue was washed with isopropyl ether, and then recrystallized from ethyl acetate/isopropyl ether to give N-(1-ethyl-2-pyrrolidinyl) as crystals with a melting point of 85-87°C. methyl)-2-methoxy-5-(N-methylethanesulfonylamino)benzamide 74η is obtained. j Using the following starting compound (9), the reaction is carried out in the same manner as in Example 1 to obtain the corresponding product (1).

実施例 23(1) 2−メトキシ一5−アミノ安息香
酸メチルエステル300η、乾燥塩化メチレン6m1お
よびトリエチルアミン368ηからなる溶液に、氷冷下
メタンスルホニルクロリド400mgおよび乾燥塩化メ
チレン1m1からなる溶液を滴下し、室温下に1時間攪
拌する。
Example 23 (1) A solution consisting of 400 mg of methanesulfonyl chloride and 1 ml of dry methylene chloride was added dropwise to a solution consisting of 300 η of 2-methoxy-5-aminobenzoic acid methyl ester, 6 ml of dry methylene chloride, and 368 η of triethylamine under ice cooling, Stir at room temperature for 1 hour.

反応液を重炭酸ナトリウム水溶液にてアルカリ性とし、
塩化メチレンにて抽出する。有機層を水洗し、芒硝で乾
燥し、塩化メチレンを減圧留去する。残渣を酢酸エチル
/イソプロピルエーテルで洗滌し、2ーメトキシ一5−
N,N−ビス(メタンスルホニル)アミノ安息香酸メチ
ルエステル520T119を得る。本品を酢酸エチルよ
り再結晶すると、融点169〜169.5℃の結晶とな
る。(2)テトラヒドロフラン3m1および10%水酸
化ナトリウム水溶液3m1からなる混液に上記生成物3
00T9を加え、50′Cに加熱下に1時間15分攪拌
する。
The reaction solution was made alkaline with an aqueous sodium bicarbonate solution,
Extract with methylene chloride. The organic layer was washed with water, dried over Glauber's salt, and methylene chloride was distilled off under reduced pressure. The residue was washed with ethyl acetate/isopropyl ether and 2-methoxy-5-
N,N-bis(methanesulfonyl)aminobenzoic acid methyl ester 520T119 is obtained. When this product is recrystallized from ethyl acetate, it becomes crystals with a melting point of 169-169.5°C. (2) Add the above product 3 to a mixture of 3 ml of tetrahydrofuran and 3 ml of 10% aqueous sodium hydroxide solution.
Add 00T9 and stir for 1 hour and 15 minutes while heating to 50'C.

反応液から溶媒を減圧留去し、残渣を6N塩酸にて酸性
とし、食塩を加えて塩析し、少量のメタノールを自む塩
化メチレンにて抽出する。有機層を飽和食塩水で洗滌し
、芒硝で乾燥し、溶媒を減圧留去する。残渣をイソプロ
ピルエーテルで洗撲し、融点166〜167.5℃の結
晶として2−メトキシ−5−メタンスルホンアミド安息
香酸175mgを得る。(3)上記生成物150〜およ
び塩化チオニル3m1からなる混合物を30分間加熱還
流する。
The solvent was distilled off from the reaction solution under reduced pressure, the residue was acidified with 6N hydrochloric acid, salted out by adding common salt, and a small amount of methanol was extracted with methylene chloride. The organic layer was washed with saturated brine, dried over sodium sulfate, and the solvent was distilled off under reduced pressure. The residue is washed with isopropyl ether to obtain 175 mg of 2-methoxy-5-methanesulfonamidobenzoic acid as crystals with a melting point of 166-167.5°C. (3) A mixture consisting of 150 ~ of the above products and 3 ml of thionyl chloride is heated under reflux for 30 minutes.

塩化チオニルを減圧留去し、残渣に乾燥ベンゼンを加え
、再び溶媒を減圧留去する。残渣を乾燥塩化メチレン3
mI!に溶解する。氷冷下この溶液に、トリエチルアミ
ン124m9および次いで1−エチル−2−アミノメチ
ルピロリジン90〜および乾燥塩化メチレン1m1から
なる溶液を滴下し、室温下に15分間攪拌する。反応液
に重炭酸ナトリウム水溶液を加えてアルカリ性とし、食
塩にて塩析し、塩化メチレンにて抽出する。有機層を飽
和食塩水にて洗滌し、芒硝で乾燥し、塩化メチレンを減
圧留去する。残渣をアルミナカ功ラムにてクロマトグラ
フイ一に付し、1%メタノール/塩化メチレン〜2%メ
タノール/塩化メチレンにて溶出する。
Thionyl chloride is distilled off under reduced pressure, dry benzene is added to the residue, and the solvent is distilled off again under reduced pressure. Dry the residue with methylene chloride 3
mI! dissolve in A solution consisting of 124 m9 of triethylamine, then 90 ~ 1-ethyl-2-aminomethylpyrrolidine, and 1 ml of dry methylene chloride was added dropwise to this solution under ice cooling, and the mixture was stirred at room temperature for 15 minutes. The reaction solution is made alkaline by adding an aqueous sodium bicarbonate solution, salted out with common salt, and extracted with methylene chloride. The organic layer was washed with saturated brine, dried over sodium sulfate, and methylene chloride was distilled off under reduced pressure. The residue was chromatographed on an alumina column and eluted with 1% methanol/methylene chloride to 2% methanol/methylene chloride.

溶出液から溶媒を留去し、残渣を酢酸エチル/イソプロ
ピルエーテルから再結晶し、N−(1−エチル−2−ピ
ロリジニルメチル)−2−メトキシ−5−メタンスルホ
ンアミドベンズアミド143mgを得る。本品を酢酸エ
チル/イソプロピルエーテルより再結晶すると、融点1
69〜170.5℃の結晶となる。υ施例 24 1) 2−メトキシ一5−アミノ安息香酸メチルエステ
ル300ηおよび乾燥ピリジン3m1からなる溶液に、
氷冷攪拌下メタンスルホニルクロリド210ηを滴下し
、室温下に1時間攪拌する。
The solvent was distilled off from the eluate, and the residue was recrystallized from ethyl acetate/isopropyl ether to obtain 143 mg of N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-methanesulfonamide benzamide. When this product is recrystallized from ethyl acetate/isopropyl ether, the melting point is 1.
It becomes a crystal at 69-170.5°C. υExample 24 1) In a solution consisting of 300η of 2-methoxy-5-aminobenzoic acid methyl ester and 3ml of dry pyridine,
While cooling with ice and stirring, 210η of methanesulfonyl chloride was added dropwise, and the mixture was stirred at room temperature for 1 hour.

反応液を6N塩酸にて酸性とし、塩化メチレンにて抽出
する。有機層を水洗し、芒硝にて乾燥し、塩化メチレン
を減圧留去する。残渣をシリカゲルカラムにてクロマト
グラフイ一に付し、塩化メチレン〜2%メタノール/塩
化メチレンにて溶出し、溶出液から溶媒を留去する。残
渣を酢酸エチル/イソプロピルエーテルから再結晶し、
融点84〜86℃の無色プリズム晶として2−メトキシ
−5−メタンスルホンアミド安息香酸メチルエステル3
81〜を得る。2)上記生成物330Tf19、1−エ
チル−2−アミノメチルピロリジン245W19および
n−プロパノール7mlからなる溶液を23時間加熱下
に還流する。
The reaction solution was made acidic with 6N hydrochloric acid and extracted with methylene chloride. The organic layer was washed with water, dried over sodium sulfate, and methylene chloride was distilled off under reduced pressure. The residue was chromatographed on a silica gel column, eluted with methylene chloride to 2% methanol/methylene chloride, and the solvent was distilled off from the eluate. The residue was recrystallized from ethyl acetate/isopropyl ether,
2-Methoxy-5-methanesulfonamidobenzoic acid methyl ester 3 as colorless prism crystals with a melting point of 84-86°C
81~ is obtained. 2) A solution consisting of the above product 330Tf19, 1-ethyl-2-aminomethylpyrrolidine 245W19 and 7 ml of n-propanol is refluxed under heating for 23 hours.

冷後、n−プロパノールを減圧留去し、残渣を希塩酸に
溶解し、未反応のエステル塩化メチレンにて抽出する。
塩酸酸性水層を重炭酸ナトリウムアルカリ性とし、食塩
にて塩析し、塩化メチレンにて抽出する。有機層を飽和
食塩水にて洗滌し、芒硝で乾燥し、塩化メチレンを減圧
留去する。残渣をアルミナカラムにてクロマトグラフイ
一に付し、2%メタノール/塩化メチレンにて溶出し、
溶出液から溶媒を留去する。残渣を酢酸エチル/イソプ
ロピルエーテルより再結晶し、融点171〜172℃の
無色鱗片晶としてN −(1−エチル−2−ピロリジニ
ルメチル)− 2 −メトキシ−5−メタンスルホンア
ミドベンズアミド143m9を得る。
After cooling, n-propanol is distilled off under reduced pressure, the residue is dissolved in dilute hydrochloric acid, and extracted with unreacted ester methylene chloride.
The hydrochloric acid acidic aqueous layer is made alkaline with sodium bicarbonate, salted out with common salt, and extracted with methylene chloride. The organic layer was washed with saturated brine, dried over sodium sulfate, and methylene chloride was distilled off under reduced pressure. The residue was chromatographed on an alumina column and eluted with 2% methanol/methylene chloride.
The solvent is distilled off from the eluate. The residue was recrystallized from ethyl acetate/isopropyl ether to obtain 143 m9 of N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-methanesulfonamide benzamide as colorless scale crystals with a melting point of 171-172°C. .

実施例 25 N−(1−エチル−2−ピロリジニルメチル)−2−メ
トキシ−4−クロロ−5−メタンスルホンアミドベンズ
アミドおよびジメチル硫酸を使用して、実施例5と同様
に反応を行い、融点140.5〜142゜Cの結晶とし
てN −(1−エチル− 2 一ピロリジニルメチル)
− 2 −メトキシ−4−クカロ一5−(N−メチルメ
タンスルホンアミド)ベンズアミドを得る。
Example 25 N-(1-ethyl-2-pyrrolidinylmethyl)-2-methoxy-4-chloro-5-methanesulfonamide A reaction was carried out as in Example 5 using benzamide and dimethyl sulfuric acid, N-(1-ethyl-2-pyrrolidinylmethyl) as a crystal with a melting point of 140.5-142°C
- Obtain 2-methoxy-4-cucaro-5-(N-methylmethanesulfonamido)benzamide.

実施例 26 2−メトキシ− 5 −( N −メチルメタンスルホ
ンアミド)安息香酸メチルエステルを使用し、実施例2
5(2)と同様に反応を行い、融点97〜98℃の結晶
としてN −(1−エチル−2−ピロリジニルメチル)
−2−メトキシ− 5 −( N −メチルメタンスル
ホンアミド)ベンズアミドを得る。
Example 26 Using 2-methoxy-5-(N-methylmethanesulfonamido)benzoic acid methyl ester, Example 2
The reaction was carried out in the same manner as in 5(2), and N-(1-ethyl-2-pyrrolidinylmethyl) was obtained as crystals with a melting point of 97-98°C.
-2-Methoxy-5-(N-methylmethanesulfonamido)benzamide is obtained.

実施例 27 2−メトキシ− 4 −メチル−5−〔(メチル)(ジ
メチルアミノスルホニル)アミノ〕安息香酸メチルエス
テルを使用し、実施例24(2)と同様に反応を行い、
融点83〜84℃の結晶としてN一(1−エチル− 2
−ピロリジニルメチル)− 2 一メトキシ一4−メ
チル−5−〔(メチル)(ジメチルアミノスルホニル)
アミノ〕ベンズアミドを得る。
Example 27 Using 2-methoxy-4-methyl-5-[(methyl)(dimethylaminosulfonyl)amino]benzoic acid methyl ester, the reaction was carried out in the same manner as in Example 24(2),
N-(1-ethyl-2) as a crystal with a melting point of 83-84°C
-pyrrolidinylmethyl)-2-1methoxy-4-methyl-5-[(methyl)(dimethylaminosulfonyl)
[Amino]benzamide is obtained.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ 〔式中、Rは水素、アルキル基、シアノ基、アルカンス
ルホニル基又はジアルキルアミノ基を表わし;R^1は
アルキル基、アリール基又はジアルキルアミノ基を表わ
し;R^2は水素、ハロゲン、アルキル基、ジアルキル
アミノ基又はアルコキシ基を表わし;R^4はアルコキ
シ基を表わし;R^3およびR^5は各々水素、アルキ
ル基又はアルコキシ基を表わし;R^6はアルキル基又
はシクロアルキル基を表わす。 〕で示される化合物又はその塩。 2 一般式 ▲数式、化学式、表等があります▼ 〔式中、Rは水素、アルキル基、シアノ基、アルカンス
ルホニル基又はジアルキルアミノ基を表わし;R^2は
水素、ハロゲン、アルキル基、ジアルキルアミノ基又は
アルコキシ基を表わし;R^4はアルコキシ基を表わし
;R^3およびR^5は各々水素、アルキル基又はアル
コキシ基を表わし;R^6はアルキル基又はシクロアル
キル基を表わす。 〕で示される化合物に一般式A−SO_2R′ 〔式中、Aは反応性基を表わし;R′はアルキル基、ア
リール基又はジアルキルアミノ基を表わす。 〕で示されるスルホン化剤を反応させることを特徴とす
る一般式▲数式、化学式、表等があります▼ 〔式中、Rはアルキル基、シアノ基、アルカンスルホニ
ル基又はジアルキルアミノ基を表わし、R^1、R^2
、R^3、R^4、R^5およびR^6は前記と同意義
を有する。 〕で示されるスルホンアミド系ベンズアミド誘導体の製
法。 3 一般式 ▲数式、化学式、表等があります▼ 〔式中、Rは水素、アルキル基、シアノ基、アルカンス
ルホニル基又はジアルキルアミノ基を表わし;R^1は
アルキル基、アリール基又はジアルキルアミノ基を表わ
し;R^2は水素、ハロゲン、アルキル基、ジアルキル
アミノ基又はアルコキシ基を表わし:R^4はアルコキ
シ基を表わし、R^3およびR^5は各々水素、アルキ
ル基又はアルコキシ基を表わし;A^1はヒドロキシ基
又は反応性基を表わす。 〕で示される化合物に一般式▲数式、化学式、表等があ
ります▼ 〔式中、R^6はアルキル基又はシクロアルキル基を表
わす。 〕で示されるアミン類を反応させることを特徴とする一
般式▲数式、化学式、表等があります▼ 〔式中、R、R^1、R^2、R^3、R^4、R^5
およびR^6は前記と同意義を有する。 〕で示されるスルホンアミド系ベンズアミド誘導体の製
造法。
[Claims] 1 General formula▲ Numerical formula, chemical formula, table, etc.▼ [In the formula, R represents hydrogen, an alkyl group, a cyano group, an alkanesulfonyl group, or a dialkylamino group; R^1 is an alkyl group, represents an aryl group or a dialkylamino group; R^2 represents hydrogen, halogen, an alkyl group, a dialkylamino group, or an alkoxy group; R^4 represents an alkoxy group; R^3 and R^5 each represent hydrogen or alkyl or an alkoxy group; R^6 represents an alkyl group or a cycloalkyl group. ] or its salt. 2 General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R represents hydrogen, an alkyl group, a cyano group, an alkanesulfonyl group, or a dialkylamino group; R^2 represents hydrogen, a halogen, an alkyl group, or a dialkylamino group. R^4 represents an alkoxy group; R^3 and R^5 each represent hydrogen, an alkyl group or an alkoxy group; R^6 represents an alkyl group or a cycloalkyl group. ] The compound represented by the general formula A-SO_2R' [wherein A represents a reactive group; R' represents an alkyl group, an aryl group or a dialkylamino group. ] There are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. that are characterized by reacting a sulfonating agent shown in ^1, R^2
, R^3, R^4, R^5 and R^6 have the same meanings as above. ] A method for producing a sulfonamide-based benzamide derivative. 3 General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R represents hydrogen, an alkyl group, a cyano group, an alkanesulfonyl group, or a dialkylamino group; R^1 represents an alkyl group, an aryl group, or a dialkylamino group represents; R^2 represents hydrogen, halogen, alkyl group, dialkylamino group, or alkoxy group; R^4 represents an alkoxy group; R^3 and R^5 each represent hydrogen, an alkyl group, or an alkoxy group; ;A^1 represents a hydroxy group or a reactive group. ] Compounds represented by the general formula ▲ have mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R^6 represents an alkyl group or a cycloalkyl group. ] There are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. that are characterized by the reaction of amines shown in [In the formula, R, R^1, R^2, R^3, R^4, R^ 5
and R^6 have the same meanings as above. ] A method for producing a sulfonamide-based benzamide derivative.
JP52008443A 1977-01-27 1977-01-27 Sulfonamide benzamide derivatives Expired JPS5920667B2 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
JP52008443A JPS5920667B2 (en) 1977-01-27 1977-01-27 Sulfonamide benzamide derivatives
ZA00780096A ZA7896B (en) 1977-01-27 1978-01-06 Meta-sulfonamido-benzamine derivatives
NZ186175A NZ186175A (en) 1977-01-27 1978-01-09 Meta-sulphonamidobenzamide derivatives
GB2296/78A GB1557019A (en) 1977-01-27 1978-01-19 Metalsulphonamido-benzamide derivatives
CA295,322A CA1085411A (en) 1977-01-27 1978-01-19 Meta-sulfonamido-benzamide derivatives
GR55228A GR70058B (en) 1977-01-27 1978-01-21
IE145/78A IE46497B1 (en) 1977-01-27 1978-01-23 Meta-sulfonamido-benzamide derivatives
AU32687/78A AU512057B2 (en) 1977-01-27 1978-01-24 Meta-sulfonamido-benzamide derivatives
IL53881A IL53881A (en) 1977-01-27 1978-01-24 Meta-sulfonamido-benzamide derivatives,processes for the production thereof and pharmaceutical or veterinary compositions containing the same
DK037278A DK154137C (en) 1977-01-27 1978-01-25 ANALOGY PROCEDURE FOR THE PREPARATION OF META-SULPHONAMIDO-BENZAMIDE DERIVATIVES
BE184636A BE863313A (en) 1977-01-27 1978-01-25 M-SULFONAMIDOBENZAMIDES
HU78SI1614A HU176613B (en) 1977-01-27 1978-01-26 Process for preparing meta-sulphonamido-benzamide derivatives
ES466366A ES466366A1 (en) 1977-01-27 1978-01-26 Meta-sulfonamido-benzamides
FR7802210A FR2378758A1 (en) 1977-01-27 1978-01-26 DERIVATIVES OF META-SULFANOMIDOBENZAMIDE AND NEW PRODUCTS THUS OBTAINED, IN PARTICULAR ANTIEMETIC AND PSYCHOTROPIC ACTIVITY
AR270868A AR225881A1 (en) 1977-01-27 1978-01-26 PROCEDURE FOR OBTAINING DERIVATIVES OF N- (2-PIRROLIDINYL-METHYL) -5-SULFONAMIDE-BENZAMINE AND ITS LIMES
CH86678A CH642945A5 (en) 1977-01-27 1978-01-26 META-SULFONAMIDO-BENZAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
SE7800982A SE426485B (en) 1977-01-27 1978-01-26 PROCEDURE FOR PREPARING META-SULPHONAMIDO-BENZAMIDE DERIVATIVE CONTAINING A PYRROLIDE REST
PH20712A PH12853A (en) 1977-01-27 1978-01-26 Meta-sulfonamido-benzamide derivatives
DE19782803651 DE2803651A1 (en) 1977-01-27 1978-01-27 M-SULPHONAMIDOBENZAMIDE DERIVATIVES
NL7801005A NL7801005A (en) 1977-01-27 1978-01-27 DERIVATIVES OF META-SULFONAMIDO-BENZAMIDE.
US05/967,011 US4351770A (en) 1977-01-27 1978-12-06 Preparation of N(2-pyrrolidinylmethyl)2-methoxy-5-benzenesulfonamidobenzamides
US06/124,728 US4328344A (en) 1977-01-27 1980-02-26 Meta-amino sulfonamido-benzamides
US06/124,726 US4350635A (en) 1977-01-27 1980-02-26 N(2-Pyrrolidinylmethyl)meta-sulfonamido-benzamides
US06/124,727 US4328155A (en) 1977-01-27 1980-02-26 Meta-sulfonamido-benzamides
US06/162,793 US4330472A (en) 1977-01-27 1980-06-25 Meta-sulfonamido-benzamide derivatives
US06/398,702 US4431663A (en) 1977-01-27 1982-07-15 Treatment of psychosis with meta-sulfonamido-benzamide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52008443A JPS5920667B2 (en) 1977-01-27 1977-01-27 Sulfonamide benzamide derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP22173483A Division JPS6017769B2 (en) 1983-11-24 1983-11-24 Meta-(sulfonamide)benzamide psychotropic drugs

Publications (2)

Publication Number Publication Date
JPS5392763A JPS5392763A (en) 1978-08-15
JPS5920667B2 true JPS5920667B2 (en) 1984-05-15

Family

ID=11693258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52008443A Expired JPS5920667B2 (en) 1977-01-27 1977-01-27 Sulfonamide benzamide derivatives

Country Status (3)

Country Link
JP (1) JPS5920667B2 (en)
BE (1) BE863313A (en)
ZA (1) ZA7896B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61265891A (en) * 1985-05-20 1986-11-25 松下電工株式会社 Wiring tool

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320630A1 (en) * 1987-11-19 1989-06-21 The Vanderbilt University Enantiometric iodobenzamides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61265891A (en) * 1985-05-20 1986-11-25 松下電工株式会社 Wiring tool

Also Published As

Publication number Publication date
ZA7896B (en) 1978-10-25
JPS5392763A (en) 1978-08-15
BE863313A (en) 1978-05-16

Similar Documents

Publication Publication Date Title
KR100915481B1 (en) Aminoquinazolines compounds
EP0442820B1 (en) Benzimidazole and azabenzimidazole derivatives, thromboxane receptor antagonists, processes for their preparation, synthesis intermediates, compositions containing them
JPH06507182A (en) N-sulfonyl-2-oxoindole derivatives, their preparation and pharmaceutical compositions in which they are present
JPH0314315B2 (en)
WO2008129288A2 (en) Disulfonamides useful in the treatment of inflammation
CZ178092A3 (en) Amidine compounds and process for preparing thereof
US4431663A (en) Treatment of psychosis with meta-sulfonamido-benzamide derivatives
US4857644A (en) Aryl sulfonopiperazines as anti-inflammatory agents
JPH06263710A (en) Hydroxyamidine derivative
JPS5920667B2 (en) Sulfonamide benzamide derivatives
JP2003532616A (en) A. Useful for the treatment of osteoporosis O. Indole derivatives
US4018773A (en) Phenylpiperazinotetrahydronaphthols and derivatives
US4556669A (en) 2,-3-Di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, production thereof and anti-inflammatory agent containing the same
JP5305593B2 (en) Preparation of highly chemical R-5- (2- (2-ethoxyphenoxyethylamino) propyl) -2-methoxybenzenesulfonamide hydrochloride
JPS5916871A (en) Sulfonamide-based benzamides
JP3901239B2 (en) Arylalkane derivatives
US4714700A (en) N-substituted 2,4-dialkoxy benzenesulfonamides and pharmaceutical compositions
US4162257A (en) N,N-dimethyl-5-phenyl-2-furamides
JPS59205383A (en) Furanopyridine derivative
US3766245A (en) 3,5-dialkoxyalkoxy-4-substituted benzoic acid esters
JPH03188060A (en) Benzylselenobenzamides obtained erom anilines and benzylamines and its preparation
US3278599A (en) 2-(benzyloxyalkyl)-4-phenylimino-1, 3-cyclopentanedione derivatives
US3577435A (en) Process for the preparation of 3-aryl-2-imino-3-indolinols and related compounds
NO881899L (en) NEW 2-AMINOALKYL-4-BENZYL-1- (2H) -PHTHALAZINO DERIVATIVES.
JPS59186915A (en) Psychotropic agent of meta-(sulfonamido)benzamide